Conceptual transparent microfluidic cartridge with a liver anatomy overlay and laboratory background; fictional equipment, not experimental imagery

THE EDITOR’S PICK

Liver-chip validation: the evidence and investment gate for a NAM

When is an additional liver-toxicity screen worth validating before a candidate advances?

READING, IN ANOTHER FORM

Four perspectives. One listening journey.

Build your own podcast

Start with the founding collection: one article from each pillar. Monthly sets will rotate when volumes are released.

  1. evidence

    Liver-chip validation: the evidence and investment gate for a NAM

    17 min · Bella

  2. delivery

    Liposomal delivery: when usable yield changes the investment case

    17 min · Bella

  3. access

    Inclisiran access: the referral queue behind an infrequent injection

    15 min · Hermione

  4. Value Inflection

    The cancer-vaccine option: finance the evidence before counting the payment

    12 min · Hermione

Create this four-article podcast

Browse listening sets and the archive

THE CLARUS COLLECTION

Four perspectives. A clearer next decision.

Browse the complete collection
01 · THE PERSPECTIVE

Evidence & development

From discovery to clinical evidence. Understand what a result establishes, and what remains uncertain.

Explore this pillar
Conceptual still life of an unlabelled medicine vial in a glass cabinet with a hospital corridor beyond
ClarusBIOTECH REVIEWTHE BIG QUESTIONS · THE VALUE OF READINESS

The Medicine We Hope Not to Need

A new antibiotic can be most valuable when it is used carefully. That creates a revealing challenge for how we fund discovery, protect effectiveness, and keep treatment available.

4 min read

02 · THE PERSPECTIVE

Delivery & enabling technology

The platforms that turn biological potential into practical medicines and devices.

Explore this pillar
Conceptual macro illustration of a transparent microfluidic device with channels and coral living-cell textures
ClarusBIOTECH REVIEWTHE BIG QUESTIONS · BIOLOGY IN MINIATURE

A Human Organ Small Enough for a Chip

Living cells and carefully engineered channels offer a new window into human biology. The important question is which part of an organ a tiny model can faithfully represent.

4 min read

03 · THE PERSPECTIVE

Access & commercial value

How promising science reaches people: scale, economics, adoption, and access.

Explore this pillar
Painterly editorial scene of an adult and older parent walking together through a sunny urban garden
ClarusBIOTECH REVIEWTHE BIG QUESTIONS · PROGRESS IN ORDINARY LIFE

What Does Getting Better Actually Feel Like?

A result can move in the right direction while a person’s daily life remains difficult. Patient-reported outcomes help research ask more precisely what improvement means.

4 min read

04 · THE PERSPECTIVE

Value Inflection Engineering

Connect evidence, access, execution, and capital around the next decision that matters.

Explore this pillar
THE NEXT PERSPECTIVE

Choose where to explore next.

From discovery to clinical evidence. Understand what a result establishes, and what remains uncertain.